{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-034186","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.761873+00:00","generated_at":"2026-06-03T18:49:13.575933+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Adial Pharmaceuticals enters ATM equity offering of up to $4.28M with H.C. Wainwright","bullets":["At-the-market offering of common stock up to $4,283,650 based on Form S-3 limitations.","Sales agent H.C. Wainwright receives 3% commission on gross proceeds from each sale.","Company to reimburse Wainwright up to $50,000 in expenses, plus $2,500 per due diligence update.","Offering continues until all shares sold or the agreement is terminated."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-034186","json":"https://secwatch.observer/filing/0001213900-24-034186.json","markdown":"https://secwatch.observer/filing/0001213900-24-034186.md","text":"https://secwatch.observer/filing/0001213900-24-034186.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390024034186/0001213900-24-034186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390024034186/ea0203748-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T18:49:13.575933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4963837ecaa5465279d35732419acac7cf3adb68","claim":"ADIAL PHARMACEUTICALS, INC. entered into At the Market Offering Agreement with H.C. Wainwright & Co., LLC (effective 2024-04-18).","evidence_excerpt":"On April 18, 2024, Adial Pharmaceuticals, Inc., a Delaware corporation (the “Company”), entered into an At the Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent” or “Wainwright”) providing for the sale by the Company of its shares of common stock, par value $0.001 per share (the “Common Stock”), from time to time, through the Sales Agent, with certain limitations on the amount of Common Stock that may be offered and sold by the Company as set forth in the ATM Agreement (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390024034186/0001213900-24-034186-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Effective","value":"2024-04-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}